Interesting ImagesAltered Biodistribution of 68Ga-DOTATOCDupont, Anne-Claire PharmD∗; Borrelly, Fanny MD†; Lecomte, Thierry MD‡; Maia, Serge PharmD∗; Santiago Ribeiro, Maria-Joao MD†Author Information From the Departments of ∗Nuclear Pharmacy †Nuclear Medicine ‡Hepatology and Gastroenterology, CHRU Hôpitaux De Tours, Tours, France. Received for publication September 3, 2020; revision accepted October 19, 2020. Conflicts of interest and sources of funding: none declared. Consent for publication: The patient provided written informed consent to publish this report. Correspondence to: Anne-Claire Dupont, PharmD, Department of Nuclear Pharmacy, CHRU Hôpitaux De Tours, 2 Blvd Tonnellé, 37044 Tours, France. E-mail: [email protected]. Clinical Nuclear Medicine: February 2021 - Volume 46 - Issue 2 - p 164-165 doi: 10.1097/RLU.0000000000003439 Buy Metrics Abstract 68Ga-DOTATOC PET/CT of a patient with metastatic neuroendocrine tumor reveals an abnormal biodistribution of the tracer with a vascular binding and a very low fixation on the known lesions despite the temporary discontinuation of “cold” somatostatin analogs. A possible interaction with a high intake of turmeric may be suspected by inhibition of hepatic uptake process. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.